Through its wholly owned subsidairy Ipca Pharmaceuticals Inc., USA
Ipca Laboratories announced that its wholly owned subsidiary, Ipca Pharmaceuticals Inc., USA has acquired, on 2 October 2018, 80% share capital of Bayshore Pharmaceuticals LLC, a New Jersey limited liability company (Bayshore), 788 Morris Turnpike, Suite 200, Short Hills, New Jersey, USA for cash @ US $ 10.286 millions.For its financial year ended 31 December, 2017, Bayshore had a total income of US $ 7.05 millions and EBIDTA of US $ 0.56 million.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
